INDIAGLYCO NSE filing

India Glycols: Unsecured Creditors Approve Scheme of Arrangement on March 24, 2026

The RealCase readMedium impact Positive

India Glycols Limited's Unsecured Creditors approved a Scheme of Arrangement on March 24, 2026. The meeting, held via Video Conference, saw 27 creditors participate. The resolution concerning the arrangement among India Glycols, Ennature Bio Pharma, and IGL Spirits was passed with the required majority.

Why it matters

The approval of a Scheme of Arrangement by unsecured creditors is a significant corporate action that can impact the company's structure and future operations.

The market read

The resolution regarding the Scheme of Arrangement was passed with the requisite majority, indicating a positive step forward for the company's restructuring plans.

India Glycols Limited convened a meeting of its Unsecured Creditors on Tuesday, March 24, 2026, pursuant to orders from the Hon'ble National Company Law Tribunal (NCLT), Allahabad Bench. The meeting was held via Video Conference to approve a Scheme of Arrangement amongst India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited, along with their respective shareholders.

The meeting, chaired by Shri L.N. Gupta, saw the participation of 27 Unsecured Creditors. The proposed Scheme of Arrangement was explained by Shri Rupark Sarswat, CEO. The voting on the resolution commenced with remote e-voting from Friday, March 20, 2026, to Monday, March 23, 2026, and continued during the meeting. The resolution concerning the Scheme of Arrangement was passed with the requisite majority, as confirmed by the Consolidated Scrutinizer's report.

The outcome of the meeting, including the voting results and the scrutinizer's report, has been disclosed and will be hosted on the company's website (www.indiaglycols.com) and NSDL's e-voting website (www.evoting.nsdl.com).

Filing to action

What to do with a filing like this

India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.

View original filing